Astra says U.S. Nexium antitrust case returns favourable ruling

LONDON, Dec 5 (Reuters) - AstraZeneca said a jury in the U.S. ruled in its favour in an antitrust litigation over heartburn drug Nexium, a case brought against it by various buying groups who challenged a previous settlement.